The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $19.93 in the last session, down -0.45% from day before closing price of $20.02. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 2.03 million shares were traded. ZLAB stock price reached its highest trading level at $20.29 during the session, while it also had its lowest trading level at $19.8005.
Ratios:
We take a closer look at ZLAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.68 and its Current Ratio is at 2.87. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $55.
BofA Securities Downgraded its Buy to Neutral on March 03, 2025, whereas the target price for the stock was revised from $29 to $36.10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 21 ’25 when Edmondson Frazor Titus III bought 14,328 shares for $19.78 per share.
Chen Yajing sold 240 shares of ZLAB for $6,439 on Nov 03 ’25. The Chief Financial Officer now owns 17,444 shares after completing the transaction at $26.83 per share. On Nov 03 ’25, another insider, Chen Yajing, who serves as the Officer of the company, bought 240 shares for $26.83 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 2204133632 and an Enterprise Value of 21543542784. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.02 while its Price-to-Book (P/B) ratio in mrq is 2.90. Its current Enterprise Value per Revenue stands at 48.782 whereas that against EBITDA is -100.768.
Stock Price History:
The Beta on a monthly basis for ZLAB is 0.93, which has changed by -0.2733212 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $44.34, while it has fallen to a 52-week low of $19.51. The 50-Day Moving Average of the stock is -28.52%, while the 200-Day Moving Average is calculated to be -38.39%.
Shares Statistics:
According to the various share statistics, ZLAB traded on average about 780.30K shares per day over the past 3-months and 693200 shares per day over the past 10 days. A total of 110.59M shares are outstanding, with a floating share count of 108.86M. Insiders hold about 2.12% of the company’s shares, while institutions hold 30.63% stake in the company. Shares short for ZLAB as of 1761868800 were 5022907 with a Short Ratio of 6.44, compared to 1759190400 on 4899193. Therefore, it implies a Short% of Shares Outstanding of 5022907 and a Short% of Float of 5.1499999999999995.
Earnings Estimates
The market rating of Zai Lab Limited ADR (ZLAB) is currently shaped by the ongoing analysis conducted by 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.23 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$1.36 and -$2.05 for the fiscal current year, implying an average EPS of -$1.61. EPS for the following year is -$0.56, with 9.0 analysts recommending between $0.55 and -$1.93.
Revenue Estimates
According to 5 analysts,. The current quarter’s revenue is expected to be $127.07M. It ranges from a high estimate of $128.4M to a low estimate of $124.4M. As of. The current estimate, Zai Lab Limited ADR’s year-ago sales were $109.07MFor the next quarter, 5 analysts are estimating revenue of $130.3M. There is a high estimate of $130.3M for the next quarter, whereas the lowest estimate is $130.3M.
A total of 8 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $551M, while the lowest revenue estimate was $456.96M, resulting in an average revenue estimate of $471.73M. In the same quarter a year ago, actual revenue was $398.99MBased on 15 analysts’ estimates, the company’s revenue will be $716.64M in the next fiscal year. The high estimate is $867M and the low estimate is $556.5M.
